Sestrin2, NFATc1, and NRF2 in PBMCs of patients with ankylosing spondylitis treated with etanercept compared to the new case patients
Background: Ankylosing spondylitis (AS) is an inflammatory autoimmune disease characterized by progressive bone destruction and pathological new bone formation. Sestrin2 is activated in inflammatory and oxidative responses and protects cells from injury. Sestrin inhibits reactive oxygen species (ROS...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Golestan University of Medical Sciences
2026-01-01
|
| Serija: | Medical Laboratory Journal |
| Teme: | |
| Online dostop: | http://mlj.goums.ac.ir/article-1-1934-en.pdf |
| Oznake: |
Brez oznak, prvi označite!
|
